Physician profile
Brett P Blake
NPI 1376772707
$1,441.45
in general payments reported to CMS, 2019-2025
21 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $69.67 · 2021: $120 · 2022: $270 · 2023: $221 · 2024: $519 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $981.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $426.47 | 2021-2025 | Rinvoq, Skyrizi |
| Genzyme Corporation | $157.42 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $123.56 | 2020-2025 | Ilumya |
| Regeneron Healthcare Solutions, INC. | $109.01 | 2022-2025 | Libtayo, Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.35 | 2024-2025 | Spevigo |
| Novartis Pharmaceuticals Corporation | $78.13 | 2023-2024 | |
| Saluda Medical Americas, INC. | $65.59 | 2024 | Evoke |
| Convatec INC. | $47.81 | 2023-2024 | |
| Amgen INC. | $46.90 | 2024 | Otezla |
| Mimedx Group, INC. | $41.32 | 2025 | |
| Pfizer INC. | $34.04 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $28.52 | 2022 | |
| Vyne Pharmaceuticals INC. | $27.37 | 2021 | |
| Leo Pharma INC. | $25.80 | 2020 | |
| Lilly USA, LLC | $23.51 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $23.29 | 2022 | |
| Hill Dermaceuticals, INC. | $22.75 | 2022 | |
| Kerecis Limited | $15.04 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $14.93 | 2024 | Collagenase Santyl |
| Janssen Biotech, INC. | $14.48 | 2020 | |
| Genentech USA, INC. | $11.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Blake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.